<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-10-07" version="190">
<accession>Q14669</accession>
<accession>D4HL82</accession>
<accession>Q14CA3</accession>
<accession>Q14CF1</accession>
<accession>Q15644</accession>
<accession>Q53R87</accession>
<accession>Q53TE7</accession>
<name>TRIPC_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase TRIP12</fullName>
<ecNumber evidence="12 14 20">2.3.2.26</ecNumber>
</recommendedName>
<alternativeName>
<fullName>E3 ubiquitin-protein ligase for Arf</fullName>
<shortName>ULF</shortName>
</alternativeName>
<alternativeName>
<fullName>HECT-type E3 ubiquitin transferase TRIP12</fullName>
</alternativeName>
<alternativeName>
<fullName>Thyroid receptor-interacting protein 12</fullName>
<shortName>TR-interacting protein 12</shortName>
<shortName>TRIP-12</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">TRIP12</name>
<name type="synonym">KIAA0045</name>
<name type="synonym">ULF</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2010" name="Nature" volume="464" first="624" last="627">
<title>Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.</title>
<authorList>
<person name="Chen D."/>
<person name="Shan J."/>
<person name="Zhu W.G."/>
<person name="Qin J."/>
<person name="Gu W."/>
</authorList>
<dbReference type="PubMed" id="20208519"/>
<dbReference type="DOI" id="10.1038/nature08820"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH MYC AND CDKN2A</scope>
<scope>MUTAGENESIS OF CYS-1959</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="DNA Res." volume="1" first="223" last="229">
<title>Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1.</title>
<authorList>
<person name="Nomura N."/>
<person name="Nagase T."/>
<person name="Miyajima N."/>
<person name="Sazuka T."/>
<person name="Tanaka A."/>
<person name="Sato S."/>
<person name="Seki N."/>
<person name="Kawarabayasi Y."/>
<person name="Ishikawa K."/>
<person name="Tabata S."/>
</authorList>
<dbReference type="PubMed" id="7584044"/>
<dbReference type="DOI" id="10.1093/dnares/1.5.223"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1995" name="Mol. Endocrinol." volume="9" first="243" last="254">
<title>Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.</title>
<authorList>
<person name="Lee J.W."/>
<person name="Choi H.-S."/>
<person name="Gyuris J."/>
<person name="Brent R."/>
<person name="Moore D.D."/>
</authorList>
<dbReference type="PubMed" id="7776974"/>
<dbReference type="DOI" id="10.1210/mend.9.2.7776974"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1801-1992</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1317</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="374" first="294" last="298">
<title>TRIP12 functions as an E3 ubiquitin ligase of APP-BP1.</title>
<authorList>
<person name="Park Y."/>
<person name="Yoon S.K."/>
<person name="Yoon J.B."/>
</authorList>
<dbReference type="PubMed" id="18627766"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.07.019"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310; SER-312; SER-991; SER-997; SER-1317 AND SER-1322</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="1540" last="1549">
<title>The HECT domain of TRIP12 ubiquitinates substrates of the ubiquitin fusion degradation pathway.</title>
<authorList>
<person name="Park Y."/>
<person name="Yoon S.K."/>
<person name="Yoon J.B."/>
</authorList>
<dbReference type="PubMed" id="19028681"/>
<dbReference type="DOI" id="10.1074/jbc.m807554200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-991; SER-1317 AND SER-1322</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="35665" last="35674">
<title>Ubiquitin-dependent and ubiquitin-independent control of subunit stoichiometry in the SWI/SNF complex.</title>
<authorList>
<person name="Keppler B.R."/>
<person name="Archer T.K."/>
</authorList>
<dbReference type="PubMed" id="20829358"/>
<dbReference type="DOI" id="10.1074/jbc.m110.173997"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SMARCC1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; SER-312 AND SER-942</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-310; SER-1030; SER-1317 AND SER-1322</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Cell" volume="150" first="697" last="709">
<title>TRIP12 and UBR5 Suppress Spreading of Chromatin Ubiquitylation at Damaged Chromosomes.</title>
<authorList>
<person name="Gudjonsson T."/>
<person name="Altmeyer M."/>
<person name="Savic V."/>
<person name="Toledo L."/>
<person name="Dinant C."/>
<person name="Grofte M."/>
<person name="Bartkova J."/>
<person name="Poulsen M."/>
<person name="Oka Y."/>
<person name="Bekker-Jensen S."/>
<person name="Mailand N."/>
<person name="Neumann B."/>
<person name="Heriche J.K."/>
<person name="Shearer R."/>
<person name="Saunders D."/>
<person name="Bartek J."/>
<person name="Lukas J."/>
<person name="Lukas C."/>
</authorList>
<dbReference type="PubMed" id="22884692"/>
<dbReference type="DOI" id="10.1016/j.cell.2012.06.039"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2012" name="Nat. Cell Biol." volume="14" first="625" last="633">
<title>TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation.</title>
<authorList>
<person name="Chio I.I."/>
<person name="Sasaki M."/>
<person name="Ghazarian D."/>
<person name="Moreno J."/>
<person name="Done S."/>
<person name="Ueda T."/>
<person name="Inoue S."/>
<person name="Chang Y.L."/>
<person name="Chen N.J."/>
<person name="Mak T.W."/>
</authorList>
<dbReference type="PubMed" id="22561347"/>
<dbReference type="DOI" id="10.1038/ncb2496"/>
</citation>
<scope>INTERACTION WITH TRADD</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-100; SER-312; SER-942; SER-991 AND SER-997</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1317 AND SER-1322</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2017" name="Hum. Genet." volume="136" first="179" last="192">
<title>Identification of new TRIP12 variants and detailed clinical evaluation of individuals with non-syndromic intellectual disability with or without autism.</title>
<authorList>
<person name="Bramswig N.C."/>
<person name="Luedecke H.J."/>
<person name="Pettersson M."/>
<person name="Albrecht B."/>
<person name="Bernier R.A."/>
<person name="Cremer K."/>
<person name="Eichler E.E."/>
<person name="Falkenstein D."/>
<person name="Gerdts J."/>
<person name="Jansen S."/>
<person name="Kuechler A."/>
<person name="Kvarnung M."/>
<person name="Lindstrand A."/>
<person name="Nilsson D."/>
<person name="Nordgren A."/>
<person name="Pfundt R."/>
<person name="Spruijt L."/>
<person name="Surowy H.M."/>
<person name="de Vries B.B."/>
<person name="Wieland T."/>
<person name="Engels H."/>
<person name="Strom T.M."/>
<person name="Kleefstra T."/>
<person name="Wieczorek D."/>
</authorList>
<dbReference type="PubMed" id="27848077"/>
<dbReference type="DOI" id="10.1007/s00439-016-1743-x"/>
</citation>
<scope>INVOLVEMENT IN CLABARS</scope>
<scope>VARIANTS CLABARS LEU-5; 338-ARG--SER-1992 DEL; 352-ARG--SER-1992 DEL; VARIANT VAL-761; HIS-1557; GLN-1595 AND LEU-1840</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2017" name="Hum. Genet." volume="136" first="377" last="386">
<title>Haploinsufficiency of the E3 ubiquitin-protein ligase gene TRIP12 causes intellectual disability with or without autism spectrum disorders, speech delay, and dysmorphic features.</title>
<authorList>
<person name="Zhang J."/>
<person name="Gambin T."/>
<person name="Yuan B."/>
<person name="Szafranski P."/>
<person name="Rosenfeld J.A."/>
<person name="Balwi M.A."/>
<person name="Alswaid A."/>
<person name="Al-Gazali L."/>
<person name="Shamsi A.M.A."/>
<person name="Komara M."/>
<person name="Ali B.R."/>
<person name="Roeder E."/>
<person name="McAuley L."/>
<person name="Roy D.S."/>
<person name="Manchester D.K."/>
<person name="Magoulas P."/>
<person name="King L.E."/>
<person name="Hannig V."/>
<person name="Bonneau D."/>
<person name="Denomme-Pichon A.S."/>
<person name="Charif M."/>
<person name="Besnard T."/>
<person name="Bezieau S."/>
<person name="Cogne B."/>
<person name="Andrieux J."/>
<person name="Zhu W."/>
<person name="He W."/>
<person name="Vetrini F."/>
<person name="Ward P.A."/>
<person name="Cheung S.W."/>
<person name="Bi W."/>
<person name="Eng C.M."/>
<person name="Lupski J.R."/>
<person name="Yang Y."/>
<person name="Patel A."/>
<person name="Lalani S.R."/>
<person name="Xia F."/>
<person name="Stankiewicz P."/>
</authorList>
<dbReference type="PubMed" id="28251352"/>
<dbReference type="DOI" id="10.1007/s00439-017-1763-1"/>
</citation>
<scope>INVOLVEMENT IN CLABARS</scope>
<scope>VARIANTS CLABARS VAL-761 AND PRO-1449--SER-1992 DEL</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2019" name="Mol. Cell" volume="74" first="1138" last="1147">
<title>An adversarial DNA N6-methyladenine-sensor network preserves Polycomb silencing.</title>
<authorList>
<person name="Kweon S.M."/>
<person name="Chen Y."/>
<person name="Moon E."/>
<person name="Kvederaviciute K."/>
<person name="Klimasauskas S."/>
<person name="Feldman D.E."/>
</authorList>
<dbReference type="PubMed" id="30982744"/>
<dbReference type="DOI" id="10.1016/j.molcel.2019.03.018"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<comment type="function">
<text evidence="12 13 14 15 17 20">E3 ubiquitin-protein ligase involved in ubiquitin fusion degradation (UFD) pathway and regulation of DNA repair (PubMed:19028681, PubMed:22884692). Part of the ubiquitin fusion degradation (UFD) pathway, a process that mediates ubiquitination of protein at their N-terminus, regardless of the presence of lysine residues in target proteins (PubMed:19028681). Acts as a key regulator of DNA damage response by acting as a suppressor of RNF168, an E3 ubiquitin-protein ligase that promotes accumulation of 'Lys-63'-linked histone H2A and H2AX at DNA damage sites, thereby acting as a guard against excessive spreading of ubiquitinated chromatin at damaged chromosomes (PubMed:22884692). In normal cells, mediates ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A, a lysine-less tumor suppressor required for p53/TP53 activation under oncogenic stress (PubMed:20208519). In cancer cells, however, isoform p19ARF/ARF and TRIP12 are located in different cell compartments, preventing isoform p19ARF/ARF ubiquitination and degradation (PubMed:20208519). Does not mediate ubiquitination of isoform p16-INK4a of CDKN2A (PubMed:20208519). Also catalyzes ubiquitination of NAE1 and SMARCE1, leading to their degradation (PubMed:18627766). Ubiquitination and degradation of target proteins is regulated by interaction with proteins such as MYC, TRADD or SMARCC1, which disrupt the interaction between TRIP12 and target proteins (PubMed:20829358). Mediates ubiquitination of ASXL1: following binding to N(6)-methyladenosine methylated DNA, ASXL1 is ubiquitinated by TRIP12, leading to its degradation and subsequent inactivation of the PR-DUB complex (PubMed:30982744).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 14 20">
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
<dbReference type="EC" id="2.3.2.26"/>
</reaction>
</comment>
<comment type="pathway" evidence="12 14 20">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="14 15 16">Interacts with MYC; leading to disrupt interaction with isoform p19ARF/ARF of CDKN2A (PubMed:20208519). Interacts with TRADD; leading to disrupt interaction with isoform p19ARF/ARF of CDKN2A (PubMed:22561347). Interacts with SMARCC1; leading to disrupt interaction with SMARCE1 (PubMed:20829358).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-308443">
<id>Q14669</id>
</interactant>
<interactant intactId="EBI-625922">
<id>Q8N726</id>
<label>CDKN2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-308443">
<id>Q14669</id>
</interactant>
<interactant intactId="EBI-1188341">
<id>P49286</id>
<label>MTNR1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-308443">
<id>Q14669</id>
</interactant>
<interactant intactId="EBI-447544">
<id>P01106</id>
<label>MYC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-308443">
<id>Q14669</id>
</interactant>
<interactant intactId="EBI-354150">
<id>P06748-1</id>
<label>NPM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="14">Nucleus</location>
<location evidence="14">Nucleoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q14669-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q14669-2</id>
<name>2</name>
<sequence type="described" ref="VSP_044328 VSP_044329"/>
</isoform>
<isoform>
<id>Q14669-3</id>
<name>3</name>
<sequence type="described" ref="VSP_044326 VSP_044328"/>
</isoform>
<isoform>
<id>Q14669-4</id>
<name>4</name>
<sequence type="described" ref="VSP_044327 VSP_044328 VSP_044329"/>
</isoform>
</comment>
<comment type="disease" evidence="18 19">
<disease id="DI-05132">
<name>Clark-Baraitser syndrome</name>
<acronym>CLABARS</acronym>
<description>An autosomal dominant disease characterized by intellectual disability, delayed psychomotor development, behavioral abnormalities, variable dysmorphic facial features, tall stature, obesity, and macrocephaly.</description>
<dbReference type="MIM" id="617752"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="23">Belongs to the UPL family. K-HECT subfamily.</text>
</comment>
<comment type="sequence caution" evidence="23">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAY14681" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="23">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAY14755" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="23">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA05837" version="2"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EC" id="2.3.2.26" evidence="12 14 20"/>
<dbReference type="EMBL" id="EU489742">
<property type="protein sequence ID" value="ACC99349.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D28476">
<property type="protein sequence ID" value="BAA05837.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC009973">
<property type="protein sequence ID" value="AAY14755.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC093384">
<property type="protein sequence ID" value="AAY14681.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC105380">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC114556">
<property type="protein sequence ID" value="AAI14557.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113891">
<property type="protein sequence ID" value="AAI13892.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L40383">
<property type="protein sequence ID" value="AAC41731.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33391.1">
<molecule id="Q14669-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS63145.1">
<molecule id="Q14669-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS63146.1">
<molecule id="Q14669-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001271143.1">
<molecule id="Q14669-3"/>
<property type="nucleotide sequence ID" value="NM_001284214.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001271144.1">
<molecule id="Q14669-2"/>
<property type="nucleotide sequence ID" value="NM_001284215.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001271145.1">
<molecule id="Q14669-4"/>
<property type="nucleotide sequence ID" value="NM_001284216.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001335244.1">
<molecule id="Q14669-3"/>
<property type="nucleotide sequence ID" value="NM_001348315.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001335245.1">
<molecule id="Q14669-2"/>
<property type="nucleotide sequence ID" value="NM_001348316.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004229.1">
<molecule id="Q14669-1"/>
<property type="nucleotide sequence ID" value="NM_004238.2"/>
</dbReference>
<dbReference type="BioGRID" id="114731">
<property type="interactions" value="84"/>
</dbReference>
<dbReference type="DIP" id="DIP-58584N"/>
<dbReference type="IntAct" id="Q14669">
<property type="interactions" value="45"/>
</dbReference>
<dbReference type="MINT" id="Q14669"/>
<dbReference type="STRING" id="9606.ENSP00000373696"/>
<dbReference type="iPTMnet" id="Q14669"/>
<dbReference type="MetOSite" id="Q14669"/>
<dbReference type="PhosphoSitePlus" id="Q14669"/>
<dbReference type="SwissPalm" id="Q14669"/>
<dbReference type="BioMuta" id="TRIP12"/>
<dbReference type="DMDM" id="2499839"/>
<dbReference type="EPD" id="Q14669"/>
<dbReference type="jPOST" id="Q14669"/>
<dbReference type="MassIVE" id="Q14669"/>
<dbReference type="MaxQB" id="Q14669"/>
<dbReference type="PaxDb" id="Q14669"/>
<dbReference type="PeptideAtlas" id="Q14669"/>
<dbReference type="PRIDE" id="Q14669"/>
<dbReference type="ProteomicsDB" id="60100">
<molecule id="Q14669-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60316"/>
<dbReference type="ProteomicsDB" id="60326"/>
<dbReference type="Antibodypedia" id="34396">
<property type="antibodies" value="69 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000283943">
<molecule id="Q14669-1"/>
<property type="protein sequence ID" value="ENSP00000283943"/>
<property type="gene ID" value="ENSG00000153827"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000389044">
<molecule id="Q14669-3"/>
<property type="protein sequence ID" value="ENSP00000373696"/>
<property type="gene ID" value="ENSG00000153827"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000389045">
<molecule id="Q14669-4"/>
<property type="protein sequence ID" value="ENSP00000373697"/>
<property type="gene ID" value="ENSG00000153827"/>
</dbReference>
<dbReference type="GeneID" id="9320"/>
<dbReference type="KEGG" id="hsa:9320"/>
<dbReference type="UCSC" id="uc002vpw.3">
<molecule id="Q14669-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9320"/>
<dbReference type="DisGeNET" id="9320"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000153827.13"/>
<dbReference type="GeneCards" id="TRIP12"/>
<dbReference type="HGNC" id="HGNC:12306">
<property type="gene designation" value="TRIP12"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000153827">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="TRIP12"/>
<dbReference type="MIM" id="604506">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617752">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14669"/>
<dbReference type="OpenTargets" id="ENSG00000153827"/>
<dbReference type="PharmGKB" id="PA36985"/>
<dbReference type="eggNOG" id="KOG0168">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="KOG0170">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156517"/>
<dbReference type="HOGENOM" id="CLU_000366_2_0_1"/>
<dbReference type="InParanoid" id="Q14669"/>
<dbReference type="KO" id="K10590"/>
<dbReference type="OMA" id="HGFNMDS"/>
<dbReference type="OrthoDB" id="34110at2759"/>
<dbReference type="PhylomeDB" id="Q14669"/>
<dbReference type="TreeFam" id="TF323674"/>
<dbReference type="BRENDA" id="2.3.2.B9">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="6.3.2.19">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="Q14669"/>
<dbReference type="Reactome" id="R-HSA-983168">
<property type="pathway name" value="Antigen processing: Ubiquitination &amp; Proteasome degradation"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="BioGRID-ORCS" id="9320">
<property type="hits" value="61 hits in 885 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TRIP12">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="TRIP12"/>
<dbReference type="GenomeRNAi" id="9320"/>
<dbReference type="Pharos" id="Q14669">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q14669"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="Q14669">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000153827">
<property type="expression patterns" value="Expressed in testis and 248 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q14669">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14669">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046966">
<property type="term" value="F:thyroid hormone receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:2000780">
<property type="term" value="P:negative regulation of double-strand break repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901315">
<property type="term" value="P:negative regulation of histone H2A K63-linked ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000779">
<property type="term" value="P:regulation of double-strand break repair"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045995">
<property type="term" value="P:regulation of embryonic development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00078">
<property type="entry name" value="HECTc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011989">
<property type="entry name" value="ARM-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR016024">
<property type="entry name" value="ARM-type_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR000569">
<property type="entry name" value="HECT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035983">
<property type="entry name" value="Hect_E3_ubiquitin_ligase"/>
</dbReference>
<dbReference type="InterPro" id="IPR004170">
<property type="entry name" value="WWE-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR037197">
<property type="entry name" value="WWE_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00632">
<property type="entry name" value="HECT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00119">
<property type="entry name" value="HECTc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF117839">
<property type="entry name" value="SSF117839"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48371">
<property type="entry name" value="SSF48371"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56204">
<property type="entry name" value="SSF56204"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50237">
<property type="entry name" value="HECT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50918">
<property type="entry name" value="WWE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1268">Autism spectrum disorder</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<feature type="initiator methionine" description="Removed" evidence="5">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="E3 ubiquitin-protein ligase TRIP12" id="PRO_0000173872">
<location>
<begin position="2"/>
<end position="1992"/>
</location>
</feature>
<feature type="domain" description="WWE" evidence="11">
<location>
<begin position="749"/>
<end position="836"/>
</location>
</feature>
<feature type="domain" description="HECT" evidence="10">
<location>
<begin position="1885"/>
<end position="1992"/>
</location>
</feature>
<feature type="region of interest" description="K-box">
<location>
<begin position="1496"/>
<end position="1570"/>
</location>
</feature>
<feature type="active site" description="Glycyl thioester intermediate" evidence="23">
<location>
<position position="1959"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="5">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6">
<location>
<position position="12"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="77"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="85"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="100"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="181"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5">
<location>
<position position="310"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 4 6">
<location>
<position position="312"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6">
<location>
<position position="942"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 6">
<location>
<position position="991"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 6">
<location>
<position position="997"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="1016"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="1030"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 3 5 7">
<location>
<position position="1317"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 5 7">
<location>
<position position="1322"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1329"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="1376"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="1377"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="1425"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1427"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_044326" evidence="21">
<original>G</original>
<variation>GRSHLGQAKHKGYSPPESRKSNSKAPKVQSNTTSELSRGHLSK</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_044327" evidence="21">
<location>
<begin position="33"/>
<end position="335"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 3 and isoform 4." id="VSP_044328" evidence="21 22">
<original>A</original>
<variation>AAASSSV</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_044329" evidence="21 22">
<original>E</original>
<variation>EAAHQVGEDEISLSTLGRVYTIDFNSMQ</variation>
<location>
<position position="784"/>
</location>
</feature>
<feature type="sequence variant" description="In CLABARS; unknown pathological significance; dbSNP:rs1300458163." id="VAR_080431" evidence="18">
<original>P</original>
<variation>L</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="sequence variant" description="In CLABARS; unknown pathological significance." id="VAR_080432" evidence="18">
<location>
<begin position="338"/>
<end position="1992"/>
</location>
</feature>
<feature type="sequence variant" description="In CLABARS; unknown pathological significance." id="VAR_080433" evidence="18">
<location>
<begin position="352"/>
<end position="1992"/>
</location>
</feature>
<feature type="sequence variant" description="In CLABARS; dbSNP:rs373429636." id="VAR_080434" evidence="18 19">
<original>A</original>
<variation>V</variation>
<location>
<position position="761"/>
</location>
</feature>
<feature type="sequence variant" description="In CLABARS." id="VAR_080435" evidence="19">
<location>
<begin position="1449"/>
<end position="1992"/>
</location>
</feature>
<feature type="sequence variant" description="In CLABARS." id="VAR_080436" evidence="18">
<original>D</original>
<variation>H</variation>
<location>
<position position="1557"/>
</location>
</feature>
<feature type="sequence variant" description="In CLABARS; dbSNP:rs1553602821." id="VAR_080437" evidence="18">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1595"/>
</location>
</feature>
<feature type="sequence variant" description="In CLABARS; dbSNP:rs866079762." id="VAR_080438" evidence="18">
<original>S</original>
<variation>L</variation>
<location>
<position position="1840"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes E3 ubiquitin-protein ligase activity." evidence="14">
<original>C</original>
<variation>A</variation>
<location>
<position position="1959"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAC41731." ref="5" evidence="23">
<original>SSIEIMREKLLIAAREGQQSFHLS</original>
<variation>QALRYA</variation>
<location>
<begin position="1969"/>
<end position="1992"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; ACC99349." ref="1" evidence="23">
<original>A</original>
<variation>T</variation>
<location sequence="Q14669-2">
<position position="380"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="F1LP64"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="G5E870"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00104"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00248"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18627766"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19028681"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20208519"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20829358"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22561347"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22884692"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27848077"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28251352"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30982744"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20208519"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000305"/>
<sequence length="1992" mass="220434" checksum="294A7C063A3332DE" modified="1997-11-01" version="1">MSNRPNNNPGGSLRRSQRNTAGAQPQDDSIGGRSCSSSSAVIVPQPEDPDRANTSERQKTGQVPKKDNSRGVKRSASPDYNRTNSPSSAKKPKALQHTESPSETNKPHSKSKKRHLDQEQQLKSAQSPSTSKAHTRKSGATGGSRSQKRKRTESSCVKSGSGSESTGAEERSAKPTKLASKSATSAKAGCSTITDSSSAASTSSSSSAVASASSTVPPGARVKQGKDQNKARRSRSASSPSPRRSSREKEQSKTGGSSKFDWAARFSPKVSLPKTKLSLPGSSKSETSKPGPSGLQAKLASLRKSTKKRSESPPAELPSLRRSTRQKTTGSCASTSRRGSGLGKRGAAEARRQEKMADPESNQEAVNSSAARTDEAPQGAAGAVGMTTSGESESDDSEMGRLQALLEARGLPPHLFGPLGPRMSQLFHRTIGSGASSKAQQLLQGLQASDESQQLQAVIEMCQLLVMGNEETLGGFPVKSVVPALITLLQMEHNFDIMNHACRALTYMMEALPRSSAVVVDAIPVFLEKLQVIQCIDVAEQALTALEMLSRRHSKAILQAGGLADCLLYLEFFSINAQRNALAIAANCCQSITPDEFHFVADSLPLLTQRLTHQDKKSVESTCLCFARLVDNFQHEENLLQQVASKDLLTNVQQLLVVTPPILSSGMFIMVVRMFSLMCSNCPTLAVQLMKQNIAETLHFLLCGASNGSCQEQIDLVPRSPQELYELTSLICELMPCLPKEGIFAVDTMLKKGNAQNTDGAIWQWRDDRGLWHPYNRIDSRIIEQINEDTGTARAIQRKPNPLANSNTSGYSESKKDDARAQLMKEDPELAKSFIKTLFGVLYEVYSSSAGPAVRHKCLRAILRIIYFADAELLKDVLKNHAVSSHIASMLSSQDLKIVVGALQMAEILMQKLPDIFSVYFRREGVMHQVKHLAESESLLTSPPKACTNGSGSMGSTTSVSSGTATAATHAAADLGSPSLQHSRDDSLDLSPQGRLSDVLKRKRLPKRGPRRPKYSPPRDDDKVDNQAKSPTTTQSPKSSFLASLNPKTWGRLSTQSNSNNIEPARTAGGSGLARAASKDTISNNREKIKGWIKEQAHKFVERYFSSENMDGSNPALNVLQRLCAATEQLNLQVDGGAECLVEIRSIVSESDVSSFEIQHSGFVKQLLLYLTSKSEKDAVSREIRLKRFLHVFFSSPLPGEEPIGRVEPVGNAPLLALVHKMNNCLSQMEQFPVKVHDFPSGNGTGGSFSLNRGSQALKFFNTHQLKCQLQRHPDCANVKQWKGGPVKIDPLALVQAIERYLVVRGYGRVREDDEDSDDDGSDEEIDESLAAQFLNSGNVRHRLQFYIGEHLLPYNMTVYQAVRQFSIQAEDERESTDDESNPLGRAGIWTKTHTIWYKPVREDEESNKDCVGGKRGRAQTAPTKTSPRNAKKHDELWHDGVCPSVSNPLEVYLIPTPPENITFEDPSLDVILLLRVLHAISRYWYYLYDNAMCKEIIPTSEFINSKLTAKANRQLQDPLVIMTGNIPTWLTELGKTCPFFFPFDTRQMLFYVTAFDRDRAMQRLLDTNPEINQSDSQDSRVAPRLDRKKRTVNREELLKQAESVMQDLGSSRAMLEIQYENEVGTGLGPTLEFYALVSQELQRADLGLWRGEEVTLSNPKGSQEGTKYIQNLQGLFALPFGRTAKPAHIAKVKMKFRFLGKLMAKAIMDFRLVDLPLGLPFYKWMLRQETSLTSHDLFDIDPVVARSVYHLEDIVRQKKRLEQDKSQTKESLQYALETLTMNGCSVEDLGLDFTLPGFPNIELKKGGKDIPVTIHNLEEYLRLVIFWALNEGVSRQFDSFRDGFESVFPLSHLQYFYPEELDQLLCGSKADTWDAKTLMECCRPDHGYTHDSRAVKFLFEILSSFDNEQQRLFLQFVTGSPRLPVGGFRSLNPPLTIVRKTFESTENPDDFLPSVMTCVNYLKLPDYSSIEIMREKLLIAAREGQQSFHLS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

